Point-Counterpoint: Genotype-Guided Warfarin Therapy.
作者信息
Lu Wenjie Jessie, Miller Nathan J
机构信息
Department of Internal Medicine, University of South Dakota Sanford School of Medicine.
出版信息
S D Med. 2017 Feb;70(2):54-56.
PMID:28810086
Abstract
摘要
相似文献
1
Point-Counterpoint: Genotype-Guided Warfarin Therapy.针锋相对：基因分型指导的华法林治疗
S D Med. 2017 Feb;70(2):54-56.
2
[Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].[CYP2C9和VKORC1基因多态性对华法林治疗起始阶段反应的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Oct;39(10):929-35.
3
The value of pharmacogenetic testing.药物遗传学检测的价值。
JAMA Intern Med. 2015 Feb;175(2):314. doi: 10.1001/jamainternmed.2014.7017.
4
Warfarin, genes, and the (health care) environment.华法林、基因与（医疗保健）环境。
JAMA Intern Med. 2014 Aug;174(8):1338-9. doi: 10.1001/jamainternmed.2014.1227.
5
The value of pharmacogenetic testing—reply.药物遗传学检测的价值——回复。
JAMA Intern Med. 2015 Feb;175(2):314-5. doi: 10.1001/jamainternmed.2014.7023.
6
Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals.12758例个体药物基因组学检测临床应用分析
Clin Transl Med. 2021 Nov;11(11):e586. doi: 10.1002/ctm2.586.
7
Q: Should we use pharmacogenetic testing when prescribing warfarin?问：我们在开具华法林处方时应该进行药物遗传学检测吗？
Cleve Clin J Med. 2013 Aug;80(8):483-6. doi: 10.3949/ccjm.80a.12184.
8
The importance of including African populations in pharmacogenetics studies of warfarin response.纳入非洲人群进行华法林反应的药物遗传学研究的重要性。
Pharmacogenomics. 2022 Jan;23(1):1-4. doi: 10.2217/pgs-2021-0142. Epub 2021 Nov 25.
9
Prevalence of Warfarin Genotype Polymorphisms in Patients with Mechanical Circulatory Support.接受机械循环支持患者华法林基因型多态性的患病率
ASAIO J. 2015 Jul-Aug;61(4):391-6. doi: 10.1097/MAT.0000000000000231.
10
Lessons learned from the influence of CYP2C9 genotype on warfarin dosing.从CYP2C9基因分型对华法林剂量的影响中吸取的经验教训。
Expert Opin Drug Metab Toxicol. 2023 Apr;19(4):185-188. doi: 10.1080/17425255.2023.2220961. Epub 2023 Jun 2.
Zotero 插件